DBV Technologies, a private limited French company, has appointed Peter Barton Hutt as a non-executive director. Mr Hutt is currently a senior counsel at Covington & Burling LLP in Washington DC. He has been a member of the US Institute of Medicine since its establishment in 1971 and was formerly chief counsel for the US Food and Drug Administration.
Based in Paris, DBV Technologies specialises in diagnostics and immunotherapies for allergy diagnosis and treatment.
Copyright 2009 Evernow Publishing Ltd